Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.
종목 코드 VVOS
회사 이름Vivos Therapeutics Inc
상장일Dec 11, 2020
CEOMr. R. Kirk Huntsman
직원 수109
유형Ordinary Share
회계 연도 종료Dec 11
주소7921 Southpark Plaza,
도시LITTLETON
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호80120
전화18669084867
웹사이트https://vivos.com/
종목 코드 VVOS
상장일Dec 11, 2020
CEOMr. R. Kirk Huntsman
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음